🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This international, multi-center, open-label, single-arm study evaluated th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-03-29
Trial ID
NCT03176238
Treatments Being Tested
The present multi-center, open-label, single-arm study aims to evaluate the...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06
Trial ID
NCT01626222
Treatments Being Tested
This Phase III, randomized, open-label, multicenter study will evaluate the...
Status
Active Not Recruiting
Location
Alaska Oncology & Hematology, LLC
Start Date
2022-08-03
Trial ID
NCT05306340
Treatments Being Tested
To explore the efficacy and safety of chidamide combined with endocrine in ...
Status
Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2023-07-20
Trial ID
NCT05983107
Treatments Being Tested
An observational study in patients with advanced ER+, HER2 negative breast ...
Status
Completed
Location
Aalborg Universitetshospital, Clinical Research unit Department of oncology, Klinik Kirurgi-kræft, Hobrovej 18-22
Start Date
2013-12
Trial ID
NCT02023359
Treatments Being Tested
To examine whether the occurrence of oral mucositis can be reduced by denta...
Status
Completed
Location
Tokai University, School of Medicine
Start Date
2015-03-26
Trial ID
NCT02376985
Treatments Being Tested
The purpose of this study is to determine whether exemestane plus everolimu...
Status
Unknown
Location
Unimed Medical Institute
Start Date
TBD
Trial ID
NCT02025712
Treatments Being Tested
The main objective of the trial is to assess the efficacy of xentuzumab in ...
Status
Completed
Location
Ironwood Cancer and Research Centers
Start Date
2018-11-28
Trial ID
NCT03659136
Treatments Being Tested
Determine the overall response rate (ORR) at 48 weeks to everolimus (RAD001...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-01-31
Trial ID
NCT01743560
Treatments Being Tested
The goal of this clinical research study is to learn if exemestane and ever...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-09
Trial ID
NCT01627067
Treatments Being Tested